Skip to content
GBC - Global BioClinical
  • Home
  • Company
    • Company Overview
    • Management Team
    • Director’s Message
    • “The Small Clinical Research Organization (CRO) Advantage”
    • Core Values
    • Memberships
    • Careers
    • Contact
  • Services
    • Consulting
      • Organizational Consulting
        • Organizations GBC Serves
      • Project Management
      • Quality Management
        • QMS Development
        • Audit Services
          • Organizations GBC Audits
      • Regulatory Support
      • Medical & Technical Writing
      • Medical & Scientific Liaison
    • Business
      • Business Intelligence
      • Strategic Alliances
        • Alliance Evaluation
        • Alliance Management
      • Business Development
      • Risk Management
      • Human Capital
    • Trials
      • Trial Strategy & Design
        • Types of Studies
        • Therapeutic Areas
        • Trial Globalization
      • Trial Preparation
      • Trial Launch
      • Site Management
      • Monitoring
      • Data Management
      • Study Supply Logistics
      • Adaptive Transition
      • Trial Close Out
    • Biospecimens
      • Sourcing
        • Common Indications
        • Common Formats
      • Biospecimen Management
      • Biorepository Management
      • Biorepository Accreditation
      • Cost Recovery
      • Tissue Research
  • Partners
    • Clients
    • Investigators
    • Industry Colleagues
  • Register
    • Registration
  • News & Events
    • In Vitro Diagnostics – IVD News
    • Press Releases
    • Events
    • GBC Blog
  • Resources
    • Links
    • Publications
    • Documents
    • Templates
    • Company Media
    • Login
  • Contact
GBC - Global BioClinical

 

  • Home
  • Company
    • Company Overview
    • Management Team
    • Director’s Message
    • “The Small Clinical Research Organization (CRO) Advantage”
    • Core Values
    • Memberships
    • Careers
    • Contact
  • Services
    • Consulting
      • Organizational Consulting
        • Organizations GBC Serves
      • Project Management
      • Quality Management
        • QMS Development
        • Audit Services
          • Organizations GBC Audits
      • Regulatory Support
      • Medical & Technical Writing
      • Medical & Scientific Liaison
    • Business
      • Business Intelligence
      • Strategic Alliances
        • Alliance Evaluation
        • Alliance Management
      • Business Development
      • Risk Management
      • Human Capital
    • Trials
      • Trial Strategy & Design
        • Types of Studies
        • Therapeutic Areas
        • Trial Globalization
      • Trial Preparation
      • Trial Launch
      • Site Management
      • Monitoring
      • Data Management
      • Study Supply Logistics
      • Adaptive Transition
      • Trial Close Out
    • Biospecimens
      • Sourcing
        • Common Indications
        • Common Formats
      • Biospecimen Management
      • Biorepository Management
      • Biorepository Accreditation
      • Cost Recovery
      • Tissue Research
  • Partners
    • Clients
    • Investigators
    • Industry Colleagues
  • Register
    • Registration
  • News & Events
    • In Vitro Diagnostics – IVD News
    • Press Releases
    • Events
    • GBC Blog
  • Resources
    • Links
    • Publications
    • Documents
    • Templates
    • Company Media
    • Login
  • Contact

Archives

NEWS

  • Teal Health Completes Clinical Trial at Record Speed and Receives FDA Breakthrough Designation for Its At-Home Cervical Cancer Screening Device, the Teal Wand™
  • OpGen Submits De Novo Request to the U.S. FDA for Unyvero Urinary Tract Infection (UTI) Panel
  • OpGen Announces Positive Top Line Data from Clinical Trial for Unyvero Urinary Tract Infection (UTI) Panel
  • InfanDx Tackles Early Detection of Hypoxic Ischemic Encephalopathy

GBC BLOG

  • Biotech firm Recursion to Buy Smaller Peer Exscientia
  • Fred Hutch Unveils Results of New Blood Test That Detects Colon Cancer
  • Bacteria Subtype Linked to Growth in Up to 50% of Human Colorectal Cancers
  • KLAS Research U.S. Digital Pathology Report Confirms Philips As One of The Industry’s Leading Players

Curetis Initiates CE Performance Evaluation

March 9, 2015

Select link below to view press release:

http://www.curetis.com/uploads/tx_news/20150309_Curetis_P55_study_initiation_EN_FINAL.pdf

Posted in GBC Blog

113 Cherry Street, Suite #80042
Seattle, WA 98104-2205 USA
PHONE: +1 888 659 1221
FAX: +1 206 299 9895
EMAIL: info@globalbioclinical.com

Visit Us On FacebookVisit Us On TwitterVisit Us On Linkedin
Copyright © GLOBAL BIOCLINICAL
Scroll To Top